Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Select Medical Holdings (SEM) Cash from Operations (2018 - 2025)

Select Medical Holdings (SEM) has disclosed Cash from Operations for 8 consecutive years, with 64325000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Cash from Operations fell 48.72% to 64325000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 346467000.0, a 33.1% decrease, with the full-year FY2025 number at 346467000.0, down 33.1% from a year prior.
  • Cash from Operations was 64325000.0 for Q4 2025 at Select Medical Holdings, down from 175307000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 278152000.0 in Q2 2024 to a low of 66689000.0 in Q1 2024.
  • A 5-year average of 106622100.0 and a median of 113315000.0 in 2023 define the central range for Cash from Operations.
  • Peak YoY movement for Cash from Operations: surged 1330.5% in 2023, then tumbled 229.64% in 2024.
  • Select Medical Holdings' Cash from Operations stood at 60752000.0 in 2021, then skyrocketed by 120.65% to 12544000.0 in 2022, then soared by 1330.5% to 179442000.0 in 2023, then tumbled by 30.1% to 125432000.0 in 2024, then crashed by 48.72% to 64325000.0 in 2025.
  • Per Business Quant, the three most recent readings for SEM's Cash from Operations are 64325000.0 (Q4 2025), 175307000.0 (Q3 2025), and 110292000.0 (Q2 2025).